labetalol has been researched along with ADDH in 3 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the functional development of children born after treatment of mild-to-moderate gestational hypertension with labetalol versus methyldopa, and no antihypertensive treatment." | 3.76 | Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. ( Eskes, TK; Gabreëls, FJ; Pasker-de Jong, PC; Pellegrino, A; van Gelder, MM; Zielhuis, GA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitton, CA | 1 |
| Steiner, MFC | 1 |
| Aucott, L | 1 |
| Pell, JP | 1 |
| Mackay, DF | 1 |
| Fleming, M | 1 |
| McLay, JS | 1 |
| Krause, I | 1 |
| Cleper, R | 1 |
| Kovalski, Y | 1 |
| Sinai, L | 1 |
| Davidovits, M | 1 |
| Pasker-de Jong, PC | 1 |
| Zielhuis, GA | 1 |
| van Gelder, MM | 1 |
| Pellegrino, A | 1 |
| Gabreëls, FJ | 1 |
| Eskes, TK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Meditation as a Complementary Therapy in the Treatment of Gestational Hypertension[NCT03873194] | 47 participants (Actual) | Interventional | 2019-04-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for labetalol and ADDH
| Article | Year |
|---|---|
In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.
Topics: Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Birth Weight; Child; Child H | 2017 |
2 other studies available for labetalol and ADDH
| Article | Year |
|---|---|
Changes in behavior as an early symptom of renovascular hypertension in children.
Topics: Angiography; Antihypertensive Agents; Atenolol; Attention Deficit Disorder with Hyperactivity; Child | 2009 |
Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study.
Topics: Antihypertensive Agents; Attention; Attention Deficit Disorder with Hyperactivity; Bed Rest; Child; | 2010 |